Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases
Berking C, Schadendorf D, Weichenthal M, Eigentler T, Mohr P, Schober K, Kiecker F, Loquai C, Debus D, Gutzmer R, Leiter-Stoeppke U (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S755-S755
Conference Proceedings Title: ANNALS OF ONCOLOGY
DOI: 10.1016/j.annonc.2020.08.1245
Authors with CRIS profile
Involved external institutions
Eberhard Karls Universität Tübingen
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Universitätsklinikum Essen
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Klinikum Nürnberg
Germany (DE)
Elbe Kliniken Stade-Buxtehude
Germany (DE)
Novartis AG
Switzerland (CH)
Germany (DE)
Charité - Universitätsmedizin Berlin
Germany (DE)
Universitätsklinikum Essen
Germany (DE)
Universitätsklinikum Schleswig-Holstein (UKSH)
Germany (DE)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Klinikum Nürnberg
Germany (DE)
Elbe Kliniken Stade-Buxtehude
Germany (DE)
Novartis AG
Switzerland (CH)
How to cite
APA:
Berking, C., Schadendorf, D., Weichenthal, M., Eigentler, T., Mohr, P., Schober, K.,... Leiter-Stoeppke, U. (2020). Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases. In ANNALS OF ONCOLOGY (pp. S755-S755). AMSTERDAM: ELSEVIER.
MLA:
Berking, Carola, et al. "Real-world analysis of dabrafenib plus trametinib in patients with BRAFV600-mutated melanoma brain metastases." Proceedings of the ESMO Virtual Congress AMSTERDAM: ELSEVIER, 2020. S755-S755.
BibTeX: Download